Medtronic announced that its offer to exchange Medtronic shares for MiniMed Group shares was oversubscribed and has now expired. Medtronic will exchange all remaining 252.8 million MiniMed shares for 55 million Medtronic shares on a pro rata basis, accepting about 18.3% of tendered shares. This marks Medtronic's full exit from MiniMed's outstanding stock. The final proration factor will be announced on October 14, 2026, with unaccepted shares returned to shareholders shortly after. This move completes Medtronic's separation from MiniMed, allowing MiniMed to operate as an independent public company.
Following Medtronic's announcement of its full exit from MiniMed shares, Medtronic's stock on Pluang is priced at USD 90.60, up 2.40% as of October 12, 2026, 20:02 WIB. Meanwhile, MiniMed Group's shares are trading lower at USD 19.48, down 1.19% at the same time. Medtronic holds a substantial market cap of $113.18 billion, contrasting with MiniMed's $5.55 billion, highlighting the size difference between the two companies.
